David R Gandara (David Gandara)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Small Cell Lung Cancer

Top Venues

JCO precision oncology

Journal for immunotherapy of cancer

JCO oncology practice

JCO global oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Petros Christopoulos, Michal Harel, Kimberly McGregor, Yehuda Brody, Igor Puzanov, Jair Bar, Yehonatan Elon, Itamar Sela, Ben Yellin, Coren Lahav, Shani Raveh, Anat Reiner Benaim, Niels Reinmuth, Hovav Nechushtan, David Farrugia, Ernesto Bustinza-Linares, Yanyan Lou, Raya Leibowitz, Iris Kamer, Alona Zer Kuch, Mor Moskovitz, Adva Levy-Barda, Ina Koch, Michal Lotem, Rivka Katzenelson, Abed Agbarya, Gillian Price, Helen Cheley, Mahmoud Abu-Amna, Tom Geldart, Maya Gottfried, Ella Tepper, Andreas Polychronis, Ido Wolf, Adam P Dicker, David P Carbone, David R Gandara
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Petros Christopoulos, Michal Harel, Kimberly McGregor, Yehuda Brody, Igor Puzanov, Jair Bar, Yehonatan Elon, Itamar Sela, Ben Yellin, Coren Lahav, Shani Raveh, Anat Reiner Benaim, Niels Reinmuth, Hovav Nechushtan, David Farrugia, Ernesto Bustinza-Linares, Yanyan Lou, Raya Leibowitz, Iris Kamer, Alona Zer Kuch, Mor Moskovitz, Adva Levy-Barda, Ina Koch, Michal Lotem, Rivka Katzenelson, Abed Agbarya, Gillian Price, Helen Cheley, Mahmoud Abu-Amna, Tom Geldart, Maya Gottfried, Ella Tepper, Andreas Polychronis, Ido Wolf, Adam P Dicker, David P Carbone, David R Gandara
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Petros Christopoulos, Michal Harel, Kimberly McGregor, Yehuda Brody, Igor Puzanov, Jair Bar, Yehonatan Elon, Itamar Sela, Ben Yellin, Coren Lahav, Shani Raveh, Anat Reiner Benaim, Niels Reinmuth, Hovav Nechushtan, David Farrugia, Ernesto Bustinza-Linares, Yanyan Lou, Raya Leibowitz, Iris Kamer, Alona Zer Kuch, Mor Moskovitz, Adva Levy-Barda, Ina Koch, Michal Lotem, Rivka Katzenelson, Abed Agbarya, Gillian Price, Helen Cheley, Mahmoud Abu-Amna, Tom Geldart, Maya Gottfried, Ella Tepper, Andreas Polychronis, Ido Wolf, Adam P Dicker, David P Carbone, David R Gandara
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Petros Christopoulos, Michal Harel, Kimberly McGregor, Yehuda Brody, Igor Puzanov, Jair Bar, Yehonatan Elon, Itamar Sela, Ben Yellin, Coren Lahav, Shani Raveh, Anat Reiner Benaim, Niels Reinmuth, Hovav Nechushtan, David Farrugia, Ernesto Bustinza-Linares, Yanyan Lou, Raya Leibowitz, Iris Kamer, Alona Zer Kuch, Mor Moskovitz, Adva Levy-Barda, Ina Koch, Michal Lotem, Rivka Katzenelson, Abed Agbarya, Gillian Price, Helen Cheley, Mahmoud Abu-Amna, Tom Geldart, Maya Gottfried, Ella Tepper, Andreas Polychronis, Ido Wolf, Adam P Dicker, David P Carbone, David R Gandara
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, James Moon, Philip C Mack, Gregory J Gerstner, Timothy F Burns, Asma Taj, Wallace L Akerley, Konstantin H Dragnev, Noel Laudi, Mary W Redman, Jhanelle E Gray, David R Gandara, Karen Kelly
Phase II study of docetaxel and trametinib in patients with KRAS mutation positive recurrent non-small cell lung cancer (NSCLC) (SWOG S1507, NCT-02642042). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Riha Vaidya, Joseph M Unger, Lu Qian, Katherine Minichiello, Roy S Herbst, David R Gandara, Joel W Neal, Ticiana A Leal, Jyoti D Patel, Konstantin H Dragnev, Saiama N Waqar, Martin J Edelman, Ellen V Sigal, Stacey J Adam, Shakun Malik, Charles D Blanke, Michael L LeBlanc, Karen Kelly, Jhanelle E Gray, Mary W Redman
Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP). JCO precision oncology 7 (2023)
Pashtoon Murtaza Kasi, Leslie A Bucheit, Jiemin Liao, Jason S Starr, Pedro C Barata, Samuel J Klempner, David R Gandara, Ardaman Shergill, Luciana Madeira da Silva, Caroline Weipert, Nicole Zhang, Christopher Pretz, Aaron I Hardin, Lesli A Kiedrowski, Justin I Odegaard
Pan-Cancer Prevalence of Microsatellite Instability-High (MSI-H) Identified by Circulating Tumor DNA and Associated Real-World Clinical Outcomes. JCO precision oncology 7 (2023)
Christian Caglevic, Christian D Rolfo, Ignacio Gil-Bazo, Andrés Felipe Cardona, Jorge Sapunar, Fred R Hirsch, David R Gandara, Gilberto Morgan, Silvia Novello, Marina-Chiara Garassino, Giannis S Mountzios, Natasha B Leighl, Denisse Bretel, Arrieta Oscar, Alfredo Addeo, Stephen V Liu, Luis Corrales-Rodríguez, Vivek Subbiah, Francisco Aboitiz, Franz Villaroel-Espindola, Felipe Reyes-Cosmelli, Ricardo Morales, Mauricio Mahave, Luis Raez, Jorge Alatorre, Edgardo S Santos, Luis Ubillos, Daniel Shao-Weng Tan, Christoph C Zielinski
The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations. JCO global oncology 8 (2022)
Xing Yi Woo, Anuj Srivastava, Philip C Mack, Joel H Graber, Brian J Sanderson, Michael W Lloyd, Mandy Chen, Sergii Domanskyi, Regina Frances Gandour-Edwards, Rebekah A Tsai, James Keck, Mingshan Cheng, Margaret Bundy, Emily L Jocoy, Jonathan W Riess, William Holland, Stephen C Grubb, James G Peterson, Grace A Stafford, Carolyn Paisie, Steven B Neuhauser, R Krishna Murthy Karuturi, Joshy George, Allen K Simons, Margaret Chavaree, Clifford G Tepper, Neal C Goodwin, Susan D Airhart, Primo N Lara, Thomas H Openshaw, Edison T Liu, David R Gandara, Carol J Bult
A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non-Small Cell Lung Cancer. Cancer research 82 (22) (2022)
Karen L Reckamp, Mary W Redman, Konstantin H Dragnev, Katherine Minichiello, Liza C Villaruz, Bryan Faller, Tareq Al Baghdadi, Susan Hines, Leah Everhart, Louise Highleyman, Vassiliki Papadimitrakopoulou, Joel W Neal, Saiama N Waqar, Jyoti D Patel, Jhanelle E Gray, David R Gandara, Karen Kelly, Roy S Herbst
Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MAP S1800A. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (21) (2022)
Wei Zou, Stephanie J Yaung, Frederike Fuhlbrück, Marcus Ballinger, Eric Peters, John F Palma, David S Shames, David R Gandara, Yuqiu Jiang, Namrata S Patil
ctDNA Predicts Overall Survival in Patients With NSCLC Treated With PD-L1 Blockade or With Chemotherapy. JCO precision oncology 5 (2022)
Natasha B Leighl, Mary W Redman, Naiyer Rizvi, Fred R Hirsch, Philip C Mack, Lawrence H Schwartz, James L Wade, William J Irvin, Sreekanth C Reddy, Jeffrey Crawford, Jeffrey D Bradley, Thomas E Stinchcombe, Suresh S Ramalingam, Jieling Miao, Katherine Minichiello, Roy S Herbst, Vassiliki A Papadimitrakopoulou, Karen Kelly, David R Gandara
Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760). Journal for immunotherapy of cancer 9 (8) (2022)
Joshua A Roth, Meghna S Trivedi, Stacy W Gray, Donald L Patrick, Debbie M Delaney, Kate Watabayashi, Paul Litwin, Parth Shah, Katherine D Crew, Monica Yee, Mary W Redman, Joseph M Unger, Vassiliki Papadimitrakopoulou, Judy Johnson, Karen Kelly, David R Gandara, Roy S Herbst, Dawn L Hershman, Scott D Ramsey
Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN). JCO oncology practice 17 (11) (2021)
David R Gandara, Martin Reck, Denis Moro-Sibilot, Julien Mazieres, Shirish Gadgeel, Stefanie Morris, Andres Cardona, Diana Mendus, Marcus Ballinger, Achim Rittmeyer, Solange Peters
Fast progression in non-small cell lung cancer: results from the randomized phase III OAK study evaluating second-line atezolizumab versus docetaxel. Journal for immunotherapy of cancer 9 (3) (2021)
Amy Burd, Richard L Schilsky, Brian J Druker, Ross L Levine, Vassiliki A Papadimitrakopoulou, Roy S Herbst, Mary W Redman, Brian J Druker, David R Gandara
Challenges and approaches to implementing master/basket trials in oncology. Blood advances 3 (14) (2020)